AMPS Contributes Key Software Tools to the THEW

The Telemetric and Holter ECG Warehouse (THEW) is a cardiac research initiative developed by the University of Rochester Medical Center (URMC) in partnership with the Food and Drug Administration (FDA).

Today,  AMPS and the THEW announce an agreement  around the sharing of a number of key software programs needed to convert the data uploaded to the THEW repository into a common standard format.

"We are delighted to contribute with our technology to the THEW program," said Fabio Badilini PhD, Chief Scientist at AMPS. He continued, "Our company is a leader in developing software tools which are compatible with almost every existing ECG format on the market and we therefore were in the best position to help and provide tools that would allow the conversion of all the data submitted to the warehouse into a unique seamless standard”.

AMPS in particular provided, among other tools, Antares, a powerful software tool dedicated to the Holter environment, capable to intelligently extract strips from most commercial holter recordings and produce standard output formats such as ISHNE and FDA HL7 xml.

The THEW director, Dr. Jean-Philippe Couderc, PhD commented, "We are glad to have AMPS LLC as a member and a contributor to our initiative. The THEW has received large sets of ECG data from pharmaceutical companies that were recorded using different equipments. Our effort has been directed toward the conversion of these data into a common format in order to ensure consistency across databases within the THEW. The technologies provided by AMPS LLC have greatly facilitated these tasks and, today, the warehouse hosts these databases and their associated clinical information consisting in 800 Holters equivalent in size to ~6.9 million 12-lead standard ECGs."

 

About THEW: The Telemetric and Holter ECG Warehouse (THEW) is a not-profit organization hosted at the University of Rochester (UR) Medical Center (NY).The THEW is a research platform for sharing data, tools and expertise for the development of ECG-related technologies. The THEW benefits from the scientific and technical heritage of the Heart Research Follow-UP program which has more than 20 years of research experience in quantitative analysis of ventricular repolarization involving animals, normal subjects, patients with genetic (Long QT Syndrome) and acquired cardiac disorders.

Striving to advance the field of cardiac safety, the THEW initiative is developed under an agreement with the Food and Drug Administration for facilitating collaborative discussions between THEW members, and for leveraging resources to implement joint projects among FDA, UR, and other public and private stakeholders. The THEW is led by individuals from the UR, the Commissioner Office of the FDA, the Center for Drug Evaluation and Research, and the Center for Devices and Radiological Health. More information can be found at www.thew-project.org.  

About AMPS llc: AMPS LLC, based in New York, NY, is a leading edge software company providing software solutions used specifically by Clinical Research Organizations and Pharmaceutical corporations in the field of quantitative ECG analysis and blood pressure monitoring and is well known for the support given to the FDA for the establishment of the HL7 XML ECG standard and for providing FDA Officials with the famous AMPS XML Viewer tool. The company’s website is www.amps-llc.com.